Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2591-2021Class II

MOSAIQ Oncology Information System

Elekta Limited / initiated 2021-09-02 / Open, Classified / root cause: software

Elekta, Inc. began a recall of MOSAIQ Oncology Information System on . FDA classified it as Class II and gives the reason as "A drug strength in MOSAIQ can be changed during the ordering process and approved, but the saved drug strength reverts to the original value". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-2591-2021
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Elekta Limited
Product
MOSAIQ Oncology Information System
Product code
IYE Accelerator, Linear, Medical
Reason for recall
A drug strength in MOSAIQ can be changed during the ordering process and approved, but the saved drug strength reverts to the original value.
Root cause tag
software
FDA root cause
Software design
Action
The recalling firm issued an "URGENT IMPORTANT FIELD SAFETY NOTIFICATION" dated August 2021 via email to its consignees on 9/2/2021. Recommendations were made to the user until a fix is available.
Quantity in commerce
31
Distribution
Distribution was made to CA, CO, FL, ID, LA, MO, MS, NC, NH, NM, NV, NY, OH, OK, PA, SD, and WA. There was no military/government distribution. Foreign distribution was made to Australia, Canada, and the United Kingdom.
Product codes and lots
MOSAIQ 2.83 when run with First Data Bank (FDB), UDI/GTIN MOSAIQ 2.83 (0858164002367)

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2591-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2591-2021Class IIOngoingVoluntary: Firm initiated